| Autor: |
Davé E; a UCB Celltech , Slough , UK., Adams R; a UCB Celltech , Slough , UK., Zaccheo O; a UCB Celltech , Slough , UK., Carrington B; a UCB Celltech , Slough , UK., Compson JE; a UCB Celltech , Slough , UK., Dugdale S; a UCB Celltech , Slough , UK., Airey M, Malcolm S; a UCB Celltech , Slough , UK., Hailu H; a UCB Celltech , Slough , UK., Wild G; a UCB Celltech , Slough , UK., Turner A; a UCB Celltech , Slough , UK., Heads J; a UCB Celltech , Slough , UK., Sarkar K; a UCB Celltech , Slough , UK., Ventom A; a UCB Celltech , Slough , UK., Marshall D; a UCB Celltech , Slough , UK., Jairaj M; a UCB Celltech , Slough , UK., Kopotsha T; a UCB Celltech , Slough , UK., Christodoulou L; a UCB Celltech , Slough , UK., Zamacona M; a UCB Celltech , Slough , UK., Lawson AD; a UCB Celltech , Slough , UK., Heywood S; a UCB Celltech , Slough , UK., Humphreys DP; a UCB Celltech , Slough , UK. |
| Abstrakt: |
An antibody format, termed Fab-dsFv, has been designed for clinical indications that require monovalent target binding in the absence of direct Fc receptor (FcR) binding while retaining substantial serum presence. The variable fragment (Fv) domain of a humanized albumin-binding antibody was fused to the C-termini of Fab constant domains, such that the VL and VH domains were individually connected to the Cκ and CH1 domains by peptide linkers, respectively. The anti-albumin Fv was selected for properties thought to be desirable to ensure a durable serum half-life mediated via FcRn. The Fv domain was further stabilized by an inter-domain disulfide bond. The bispecific format was shown to be thermodynamically and biophysically stable, and retained good affinity and efficacy to both antigens simultaneously. In in vivo studies, the serum half-life of Fab-dsFv, 2.6 d in mice and 7.9 d in cynomolgus monkeys, was equivalent to Fab'-PEG. |
